Status:
COMPLETED
Treatment of Pathological Gambling With Naltrexone Pharmacotherapy and Brief Intervention
Lead Sponsor:
Finnish Institute for Health and Welfare
Conditions:
Pathological Gambling
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The aim of this research is to explore the efficacy of the opiate antagonist, naltrexone as combined with CBT-intervention in the treatment of pathological gambling (PG). The study period is 2011-2014...
Detailed Description
All participants have to be able to read and understand the patient information sheet and sign the informed consent. All participants are free to stop being in the study whenever they wanted. The pati...
Eligibility Criteria
Inclusion
- pathological gambling (scores 5+ from SOGS-R and DSM-IV criteria)
Exclusion
- acute hepatitis
- severe liver or kidney dysfunction
- suicide risk or severe depression or other untreated mental health problem
- participation to other gambling research at the same time
- the use of drugs (especially opiates)
- pregnancy
- prisoners
- retarded and mentally ill patients were also excluded
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2013
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01528007
Start Date
January 1 2011
End Date
September 1 2013
Last Update
December 5 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institute for Health and Welfare
Helsinki, Uusimaa, Finland, 00530